Germany and the UK have been the bastions of free pharmaceutical pricing in Europe. The situation is set to change, with new legislation promising upheaval and uncertainty.
Article by Timothy Fitzgerald and Jim Furniss of Bridgehead International, Business Development and Licensing Journal, January 2011.
Click here to access article: the_end_of_free_pricing_as_we_know_it.pdf
